多替阿巴拉米片治疗什么

What to treat?

Dolutegravir is an antiviral drug. The main function of Dolutegravir is to treat AIDS. Dolutegravir can inhibit HIV integrase by binding to the active site of integrase and blocking the strand transfer step of reverse transcription deoxyribonucleic acid (DNA) integration (a key step in the HIV replication cycle).

  Dolutegra (Simeika) is indicated for the treatment of adults and adolescents over 12 years old (with a body weight of at least 40 kg) infected with human immunodeficiency virus (HIV). HIV-infected patients, regardless of race, should be screened for the HLA-B5701 allele before starting treatment with abacavir-containing products. If the patient is known to carry the HLA-B5701 allele, he should not take products containing abacavir. 

Dolutegravir tablets (Simeike) are currently the only three-in-one compound drug containing dolutegravir (DTG). One tablet contains three antiviral drugs. Treatment drugs for different stages of viral infection are integrated in the same tablet. One tablet is a complete treatment plan. One tablet a day can achieve the effect of cocktail therapy without food restrictions.

Taking doptabalamid tablets (Suimeike) for treatment will also produce certain side effects or adverse reactions, including: nausea/insomnia/dizziness/headache, etc. Patients must go to the hospital for a detailed examination before receiving treatment with Doptabalamid Tablets (Suimeike), and take medication in accordance with the doctor's diagnosis and treatment recommendations. Patients with abacavir hypersensitivity often experience symptoms such as nausea/vomiting/diarrhea/fever/drowsiness/rash when using dolutea abacavir tablets (Simeike). If patients experience these symptoms, they should be carefully evaluated for the presence of such a hypersensitivity reaction.

The above is the introduction about (Sui Mei Kai). If patients have other questions about the drug (such as drug price, purchasing channels, etc.), they can consult the medical companion travel service.